Related Experiment Video
Updated: Oct 8, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
The roles of long non-coding RNAs in lung cancer
Zhe Cao1, Linda Oyang1, Xia Luo1
1Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China.
Abstract:
Lung cancer is the most common malignancy, being a serious threat of human lives. The incidence and mortality of lung cancer has been increasing rapidly in the past decades. Although the development of new therapeutic modes, such as target therapy, the overall survival rate of lung cancer remains low. It is urgent to advance the understanding of molecular oncology and find novel biomarkers and targets for the early diagnosis, treatment, and prognostic prediction of lung cancer. Long non-coding RNAs (lncRNAs) are non-protein coding RNA transcripts that are more than 200 nucleotides in length. LncRNAs exert diverse biological functions by regulating gene expressions at transcriptional, translational, and post-translational levels. In the past decade, it has been shown that lncRNAs are extensively involved in the pathogenesis of various diseases, including lung cancer. In this review, we highlighted the lncRNAs characterized in lung cancer and discussed their translational potential in lung cancer clinics.
Insights
Long non-coding RNAs (lncRNAs) play a crucial role in lung cancer development. Understanding these molecules offers new diagnostic and therapeutic strategies for this common malignancy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer is a leading cause of cancer-related mortality worldwide.
- Current treatments, including targeted therapies, have limited impact on overall survival rates.
- There is a critical need for novel biomarkers and therapeutic targets for improved lung cancer management.
Purpose of the Study:
- To review characterized long non-coding RNAs (lncRNAs) implicated in lung cancer pathogenesis.
- To discuss the translational potential of lncRNAs in clinical applications for lung cancer.
Main Methods:
- Literature review of studies on lncRNAs in lung cancer.
- Analysis of lncRNA functions at transcriptional, translational, and post-translational levels.
- Evaluation of lncRNAs as diagnostic, prognostic, and therapeutic targets.
Main Results:
- lncRNAs are extensively involved in the molecular mechanisms of lung cancer.
- Specific lncRNAs have been identified and characterized in lung cancer.
- These lncRNAs demonstrate potential as biomarkers and therapeutic targets.
Conclusions:
- lncRNAs represent a promising area for advancing lung cancer research.
- Further investigation into lncRNA functions can lead to improved early diagnosis, treatment, and prognosis.
- Translational studies are essential to integrate lncRNAs into clinical practice for lung cancer patients.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Types of RNA
RNA Performs Diverse...
MicroRNAs
Non-LTR Retrotransposons
RNA Splicing
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
